TY - JOUR
T1 - Osteonecrosis secondary to antiphospholipid syndrome
T2 - A case report, review of the literature, and treatment strategy
AU - Haque, Waqar
AU - Kadikoy, Huseyin
AU - Pacha, Omar
AU - Maliakkal, Joseph
AU - Hoang, Vu
AU - Abdellatif, Abdul
PY - 2010/4
Y1 - 2010/4
N2 - Osteonecrosis is commonly present in patients with antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE). Treatment of this condition remains extremely controversial. We present a treatment strategy of avascular necrosis of the knee in a patient with catastrophic antiphospholipid syndrome with a history of SLE and APS. Aggressive treatment with 12 rounds of plasmapheresis, intravenous immunoglobulin, rituximab, and cylophospha-mide led to the patient's recovery with no recurrence of symptoms during 16 months of follow up. In this report, we further discuss the pathogenesis of osteonecrosis and current understanding of the treatment of this disease.
AB - Osteonecrosis is commonly present in patients with antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE). Treatment of this condition remains extremely controversial. We present a treatment strategy of avascular necrosis of the knee in a patient with catastrophic antiphospholipid syndrome with a history of SLE and APS. Aggressive treatment with 12 rounds of plasmapheresis, intravenous immunoglobulin, rituximab, and cylophospha-mide led to the patient's recovery with no recurrence of symptoms during 16 months of follow up. In this report, we further discuss the pathogenesis of osteonecrosis and current understanding of the treatment of this disease.
KW - Antiphospholipid syndrome
KW - Osteonecrosis
KW - Systemic lupus erythematosus
UR - http://www.scopus.com/inward/record.url?scp=77951025811&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77951025811&partnerID=8YFLogxK
U2 - 10.1007/s00296-009-1269-9
DO - 10.1007/s00296-009-1269-9
M3 - Review article
C2 - 20012628
AN - SCOPUS:77951025811
SN - 0172-8172
VL - 30
SP - 719
EP - 723
JO - Rheumatology International
JF - Rheumatology International
IS - 6
ER -